The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Panacea Biotec Ltd

Panacea Biotec Ltd

BSE 531349 · NSE PANACEABIO · ISIN INE922B01023 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹393.10

-1.26%

BSE close, 28 August 2026

Market cap

₹2,407.77 cr

6.1 cr shares · Micro cap

Free float

₹652.65 cr

as published

P/E · P/B

-110.4× · 7.60×

EPS ₹-3.56 · BV ₹51.72

FY25-26 rev / PAT

413.49 / -29.88

₹ cr, as filed

Filings, window

23

3 selected · 13%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹293.10 52-WK HIGH ₹647.50 ₹393.10 28% of range
Against 52-week high-39.3%
Against 52-week low+34.1%
Day change-1.26%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-3.56
Price / earnings-110.42×
Price / book7.60×
Book value — derived, price ÷ P/B₹51.72
Return on equity-6.88%
Operating margin9.92%
Net margin1.03%

Consistency check

P/B ÷ P/E, which must equal ROE
-6.88%
ROE as published
-6.88%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 134.71 1.39 0.23 9.92% 1.03%
Mar-26 · Q 111.12 -0.18 -0.03 5.31% -0.16%
FY25-26 413.49 -29.88 -4.88 0.05% -7.23%

Quarter on quarter

Revenue, quarter on quarter
+21.2%
Net profit, quarter on quarter
+872.2%
Operating margin, quarter on quarter
+461 bps

Disclosure profile 23 filings in the window

0 median 17.0 p75 · 25 sector max 52 23 72th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Order / Contract1
Results1
Selected sub-total3
Procedural
General7
Newspaper Publication5
AGM / EGM4
Annual Report1
BRSR1
Book Closure1
Compliance Certificate1
Procedural sub-total20
Total23

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

23 filings · 3 selected · busiest 2026-09-07

Filing rhythm · the twelve most recent

2026-09-072026-10-09

SelectedProcedural

Filings

23 in the window · 11 earlier on record

  1. 9 October 2026 ·

    Newspaper Publication

    Newspaper Publication

    Please find attached newspaper copies regarding notice intimating the investors about the opening of special window for transfer and dematerialisation of physical shares

    Company Update / Newspaper Publication View filing →

  2. 7 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please find attached certificate dated October 01, 2026 issued by Skyline Financial Services Pvt. Ltd. ("RTA") confirming compliance under Regulation 74(5) of the SEBI (Depositories and ....

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  3. 7 October 2026 ·

    General

    531349 - Details Of Shares Dematerialized During September 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018

    Please find attached details of shares dematerialised during September 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

    Company Update / General View filing →

  4. 1 October 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Please find attached voting results of 42nd Annual General Meeting of the Company held on 29.09.2026 along with Scrutinizer's Report

    AGM/EGM / AGM View filing →

  5. 1 October 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Please find attached voting results of 42nd Annual General Meeting held on 29.09.2026 along with Scrutinizer's Report

    AGM/EGM / AGM View filing →

  6. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Please find attached proceedings of the 42nd Annual General meeting of the Company held on Tuesday, September 29, 2026 at 11:30 A.M. through Video Conferencing.

    AGM/EGM / AGM View filing →

  7. 29 September 2026 ·

    General

    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')

    We would like to inform you that the Company has received 2 Demand Orders dated 28.09.2026, from the Office of the Assistant Commissioner of Inc ome Tax, Delhi imposing penalty on account ....

    Company Update / General View filing →

  8. 15 September 2026 ·

    General

    Communication Sent To Physical Shareholders To Furnish PAN And KYC Details

    Please note that reminder letters dated 15.09.2026, is being sent to the shareholders holding shares in physical mode, requesting them to furnish PAN and KYC details for updation, to the ....

    Company Update / General View filing →

  9. 8 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Please find enclosed copies of newspaper advertisement regarding Notice of 42nd AGM, Cut-off date and Remote e-Voting information, published on September 08, 2026.

    Company Update / Newspaper Publication View filing →

  10. 7 September 2026 ·

    Book Closure

    Book Closure For Annual General Meeting

    Please find attached intimation regarding Book Closure for the purpose of Annual General Meeting.

    Corp. Action / Book Closure View filing →

  11. 7 September 2026 ·

    General

    Confirmation On Letter Being Sent To The Concerned Shareholders Providing The Weblink For Accessing The Annual Report For Financial Year 2025-26 And The Notice Of The Ensuing AGM, To Be Held On September 29, 2026, Through Video Conferencing / Other Audio-Visual Means.

    Please find attached intimation of letter being sent to shareholders for providing web-link for accessing Annual Report and AGM Notice for FY 2025-26

    Company Update / General View filing →

  12. 7 September 2026 ·

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    Please find attached Business Responsibility and Sustainability Report for FY 2025-26

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  13. 7 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Please find attached Annual Report for FY 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  14. 7 September 2026 ·

    AGM / EGM

    Notice Of Annual General Meeting To Be Held On September 29, 2026

    Please find attached Annual Report for Financial Year 2025-26 including Notice of AGM

    AGM/EGM / AGM View filing →

  15. 7 September 2026 ·

    General

    Details Of Shares Dematerialized During August 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018

    Please find attached details of shares dematerialised during August 2026. A copy of the certificate obtained from the Company's RTA viz. Skyline Financial Services Pvt. Ltd. regarding ....

    Company Update / General View filing →

  16. 18 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Please find enclosed newspaper copies of the public notice, requesting shareholders to register their email addresses with the Company in connection with ensuing AGM of the Company.

    Company Update / Newspaper Publication View filing →

  17. 14 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Please find attached of the extract of statement of Unaudited Financial Results for the quarter ended 30.06.2026, published on 14.08.2026.

    Company Update / Newspaper Publication View filing →

  18. 13 August 2026 ·

    Results

    Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2026

    Please find attached Unaudited Financial Results for quarter ended June 30, 2026.

    Result / Financial Results View filing →

  19. 13 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026

    Please find attached Outcome of Board Meeting held on August 13, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  20. 12 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Please find attached newspaper copies regarding notice intimating the investors about the opening of Special Window for transfer and dematerialisation of physical shares.

    Company Update / Newspaper Publication View filing →

  21. 5 August 2026 ·

    General

    Details Of Shares Dematerialized During July 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018

    Please find attached details of shares dematerialised during July 2026.

    Company Update / General View filing →

  22. 5 August 2026 ·

    Order / Contract

    Award_of_Order_Receipt_of_Order

    We are delighted to inform you that the Company has received Letter of Award for supply of bivalent Oral Polio Vaccine (bOPV) to UNICEF in 10 and 20 dose presentation worth ~US$8.205 million ....

    Company Update / Award of Order / Receipt of Order View filing →

  23. 24 July 2026 ·

    General

    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')

    The Company's wholly owned subsidiary, Panacea Biotec Pharma Ltd. has received a Show Cause Notice (SCN) dated July 23, 2026, from the office of the Assistant Commissioner, Goods and Services ....

    Company Update / General View filing →

RSS feed for Panacea Biotec Ltd · the 50 most recent filings